_________
false
פרוטליקס ביות'רפיוטיקס אינק.
2
381
PROTALIX BIOTHERAPEUTICS, INC
Corporation no:
P95000091803
8329
Israel Securities Authority
Tel Aviv Stock Exchange
C003
(
Public
)
Reported via MAGNA:
22/07/2019
www.isa.gov.il
www.tase.co.il
Reference:
2019-02-075799
Time of broadcast:
23:33
23:32:49
Other Report or Announcement
Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
8-k
8-KL_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
NASDAQ
Date of revision of form structure:
25/06/2019
Address:
Snunit
2, P.O.B 455
,
Carmiel
20100
ISRAEL
,
Tel:
04-9889488
,
Fax:
04-9889489
E-mail address:
yossim@protalix.com
Company site:
www.protalix.com
Previous names of reporting entity:
Name of the Signatory:
Maimon Yossef
Position of Signatory in the reporting corporation:
Chief Financial Officer
Name of Employer Company:
Protalix Ltd
Address:
סנונית
2
,
כרמיאל
20100
Telephone:
04-9889488
Facsimile:
04-9889489
E-mail:
yossim@protalix.com
1